Market Overview

Jefferies Downgrades Regeneron Pharmaceuticals, Inc. to Hold, Maintains $179.00 PT

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for REGN

DateFirmActionFromTo
Mar 2017UBSInitiates Coverage OnBuy
Feb 2017PiperJaffrayUpgradesNeutralOverweight
Dec 2016BMO CapitalInitiates Coverage OnMarket Perform

View More Analyst Ratings for REGN
View the Latest Analyst Ratings

Posted-In: News Downgrades Analyst Ratings

 

Related Articles (REGN)